title: Severe hidradenitis suppurative in an HIV-positive male: use of multiple treatment modalities, including tumor necrosis factor blockade.
authors.forename: Husein
authors.initials: H
authors.lastname: Husein-ElAhmed
authors.forename: Maria-Antonia
authors.initials: MA
authors.lastname: Fernandez-Pugnaire
authors.forename: Jose-Carlos
authors.initials: JC
authors.lastname: Ruiz-Carrascosa
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003879:Dermatologic Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D017497:Hidradenitis Suppurativa / Q000150:complications / Q000473:pathology / Q000628:therapy*; D006801:Humans; D000069285:Infliximab; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D019380:Anti-HIV Agents; D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab